Bank of America’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $316K | Sell |
45,989
-10,146
| -18% | -$69.8K | ﹤0.01% | 5028 |
|
2025
Q1 | $162K | Sell |
56,135
-35,731
| -39% | -$103K | ﹤0.01% | 5312 |
|
2024
Q4 | $432K | Sell |
91,866
-8,049
| -8% | -$37.8K | ﹤0.01% | 4825 |
|
2024
Q3 | $357K | Buy |
99,915
+30,029
| +43% | +$107K | ﹤0.01% | 4858 |
|
2024
Q2 | $433K | Buy |
69,886
+8,233
| +13% | +$51K | ﹤0.01% | 4660 |
|
2024
Q1 | $582K | Sell |
61,653
-125,819
| -67% | -$1.19M | ﹤0.01% | 4469 |
|
2023
Q4 | $1.27M | Buy |
187,472
+48,428
| +35% | +$327K | ﹤0.01% | 3977 |
|
2023
Q3 | $617K | Buy |
139,044
+6,806
| +5% | +$30.2K | ﹤0.01% | 4352 |
|
2023
Q2 | $436K | Buy |
132,238
+89,868
| +212% | +$297K | ﹤0.01% | 4560 |
|
2023
Q1 | $121K | Sell |
42,370
-15,263
| -26% | -$43.5K | ﹤0.01% | 5385 |
|
2022
Q4 | $420K | Buy |
57,633
+27,815
| +93% | +$202K | ﹤0.01% | 4805 |
|
2022
Q3 | $242K | Sell |
29,818
-73,849
| -71% | -$599K | ﹤0.01% | 5088 |
|
2022
Q2 | $508K | Buy |
103,667
+88,836
| +599% | +$435K | ﹤0.01% | 4729 |
|
2022
Q1 | $351K | Sell |
14,831
-13,133
| -47% | -$311K | ﹤0.01% | 5342 |
|
2021
Q4 | $495K | Buy |
27,964
+20,496
| +274% | +$363K | ﹤0.01% | 5113 |
|
2021
Q3 | $211K | Sell |
7,468
-2,809
| -27% | -$79.4K | ﹤0.01% | 5432 |
|
2021
Q2 | $108K | Buy |
10,277
+5,272
| +105% | +$55.4K | ﹤0.01% | 5692 |
|
2021
Q1 | $59K | Sell |
5,005
-11,967
| -71% | -$141K | ﹤0.01% | 5894 |
|
2020
Q4 | $199K | Buy |
16,972
+13,305
| +363% | +$156K | ﹤0.01% | 4887 |
|
2020
Q3 | $29K | Sell |
3,667
-12,665
| -78% | -$100K | ﹤0.01% | 5541 |
|
2020
Q2 | $298K | Buy |
16,332
+818
| +5% | +$14.9K | ﹤0.01% | 4458 |
|
2020
Q1 | $186K | Buy |
15,514
+13,665
| +739% | +$164K | ﹤0.01% | 4568 |
|
2019
Q4 | $31K | Sell |
1,849
-1,321
| -42% | -$22.1K | ﹤0.01% | 5567 |
|
2019
Q3 | $22K | Buy |
+3,170
| New | +$22K | ﹤0.01% | 5726 |
|